Preventive administration of bovine colostral immunoglobulins for foal diarrhea with rotavirus.

This research article investigates the effects of administering bovine colostral immunoglobulin powder on the outbreak of foal diarrhea due to serotype 3 rotavirus on a foal-raising farm, with results suggesting its potential to reduce the incidence of the disease.

Overview of the Research

• The research was conducted during two diarrhea outbreaks due to the serotype 3 rotavirus in foals on a farm in the years 1987 and 1989.
• The aim was to evaluate the effect of orally administering bovine colostral immunoglobulin (Ig) powder to the foals during these outbreaks.

Methodology and Approach

• In the 1987 outbreak, foals were not administered with Ig powder. Observations on the progression and morbidity rates of the disease were made.
• During the 1989 outbreak, all the foals, whether they had diarrhea symptoms or not, were given Ig powder orally for a period of 3 to 5 days.
• The outcomes of administering Ig powder were then compared with those of the 1987 outbreak.

Research Findings

• The research found that the morbidity – that is the incidence or prevalence – of diarrhea among the foals in 1989 was lower compared to the 1987 outbreak when the Ig powder was not administered.
• This implies that the administration of the Ig powder might have played a role in reducing instances of rotavirus-induced foal diarrhea.

Conclusion

• This study suggests that bovine colostral immunoglobulin, given orally to foals during a rotavirus epidemic, could potentially reduce the incidence of foal diarrhea induced by rotavirus infection.
• However, the research is careful to indicate that the Ig powder might only partially prevent the disease, implying further research might be needed to determine more definite results or to explore more comprehensive solutions.